期刊文献+

24例舍曲林合并重复经颅磁刺激治疗难治性强迫症患者临床观察 被引量:9

Clinical Observation on 24 Cases of Sertraline Combined With Repetitive Transcranial Magnetic Stimulation in the Treatment of Patients With Refractory Obsessive Compulsive Disorder
下载PDF
导出
摘要 目的探讨舍曲林合并重复经颅磁刺激治疗难治性强迫症的临床疗效。方法选择我院收治的难治性强迫症患者作为研究对象,随机分组为观察组和对照组各24例,比较两组患者治疗前后的效果。结果观察组Y-BOCS评分低于治疗前,观察组治疗后WHOQOL-100评量表的各项指标评分优于对照组,差异具有统计学意义,P<0.05。结论采用舍曲林合并重复经颅磁刺激治疗难治性强迫症具有明显的疗效和良好的安全性。 Objective To evaluate the clinical efficacy of sertraline combined with repetitive transcranial magnetic stimulation in the treatment of patients with refractory obsessive compulsive disorder. Methods Patients with refractory obsessive compulsive disorder in our hospital were selected as the research object and randomly divided into observation group and control group,24 cases in each group,to compare the curative effect of two groups before and after treatment. Results After treatment,the Y-BOCS score of observation group was significantly lower than that before treatment,the factorial scores of WHOQOL-100 rating scale of observation group were significantly better than that of control group,the difference was statistically significant,P〈0.05. Conclusion Application of sertraline combined with repetitive transcranial magnetic stimulation in the treatment of patients with refractory obsessive compulsive disorder(OCD) has the obviously curative effect and good safety.
作者 赵永明
出处 《中国卫生标准管理》 2016年第9期110-111,共2页 China Health Standard Management
关键词 舍曲林 重复经颅磁刺激治疗 难治性强迫症 Sertraline Repetitive transcranial magnetic stimulation efractory obsessive compulsive disorder
  • 相关文献

参考文献8

二级参考文献68

  • 1周云飞,张亚林.难治性强迫症研究进展[J].中国神经精神疾病杂志,2004,30(6):477-478. 被引量:26
  • 2喻东山.强迫症治疗的新进展[J].中华精神科杂志,2005,38(1):50-52. 被引量:65
  • 3梁海翔,李翔,任丽娜.奎硫平与氯丙嗪辅助碳酸锂治疗躁狂发作疗效分析[J].临床精神医学杂志,2005,15(3):173-174. 被引量:15
  • 4张一,孟凡强,崔玉华,甘向东,郭伟.修改耶鲁—布朗强迫量表的临床信度和效度研究[J].中国心理卫生杂志,1996,10(5):205-207. 被引量:88
  • 5Pallanti S, Quercioli L, KoranLM. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial [ J ]. J Clin Psychiatry ,2002,63 : 796. 被引量:1
  • 6Kordon A, Wahl K, Koch N, et al. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study [J]. J Clin Psychopharmacol,2008 ,28 :550-554. 被引量:1
  • 7Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder[ J]. Mol Psychiatry ,2006,11 : 622- 632. 被引量:1
  • 8Husted DS, Shapira NA. A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation[ J]. CNS Spectr,2004,9 : 833-847. 被引量:1
  • 9Savas HA, Yumru M, Ozen ME. Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder:a retrospective comparative study [ J ]. Clin Drug Investig, 2008,28 : 439- 442. 被引量:1
  • 10Dell'Osso B, Mundo E, Ahamura AC. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series [ J]. CNS Spectr,2006: 879-883. 被引量:1

共引文献69

同被引文献72

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部